Teladoc (TDOC) Announces Second Consecutive Win in Patent Dispute

August 25, 2016 1:03 PM EDT

News and research before you hear about it on CNBC and others. Claim your 2-week free trial to StreetInsider Premium here.

Teladoc, Inc. (NYSE: TDOC), the nation’s first and largest telehealth provider, today announced the U.S. Patent and Trademark Office (USPTO) has invalidated the major elements of a telemedicine patent held by American Well Corporation on the basis that they were not patentable because American Well did not invent them. The USPTO took this action at the request of Teladoc. At issue before the USPTO were the same elements of the American Well patent that a Massachusetts federal court declared invalid earlier this year on a separate basis.

“For more than a year, we have challenged American Well’s patent portfolio as invalid, advocating on behalf of the industry so innovation and increased access to health care can continue to thrive,” said Adam Vandervoort, Teladoc chief legal officer. “Teladoc is extremely pleased by the decisions of both the U.S. Patent and Trademark Office and the Massachusetts federal court.”

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

Corporate News, Litigation, Management Comments

Add Your Comment